These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9636675

  • 21. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.
    Kolch W.
    Biochem J; 2000 Oct 15; 351 Pt 2(Pt 2):289-305. PubMed ID: 11023813
    [Abstract] [Full Text] [Related]

  • 22. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL.
    Shirouzu M, Hashimoto K, Kikuchi A, Yokoyama S.
    Biochemistry; 1999 Apr 20; 38(16):5103-10. PubMed ID: 10213614
    [Abstract] [Full Text] [Related]

  • 23. Active Ras induces heterodimerization of cRaf and BRaf.
    Weber CK, Slupsky JR, Kalmes HA, Rapp UR.
    Cancer Res; 2001 May 01; 61(9):3595-8. PubMed ID: 11325826
    [Abstract] [Full Text] [Related]

  • 24. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p.
    Schmitz HP, Jöckel J, Block C, Heinisch JJ.
    J Mol Biol; 2001 Aug 03; 311(1):1-7. PubMed ID: 11469853
    [Abstract] [Full Text] [Related]

  • 25. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 26. Role of Raf-1 conserved region 2 in regulation of Ras-dependent Raf-1 activation.
    Sendoh H, Hu CD, Wu D, Song C, Yamawaki-Kataoka Y, Kotani J, Okada T, Shima F, Kariya K, Kataoka T.
    Biochem Biophys Res Commun; 2000 May 19; 271(3):596-602. PubMed ID: 10814507
    [Abstract] [Full Text] [Related]

  • 27. Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms.
    Barnard D, Diaz B, Clawson D, Marshall M.
    Oncogene; 1998 Sep 24; 17(12):1539-47. PubMed ID: 9794231
    [Abstract] [Full Text] [Related]

  • 28. Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide.
    Chie L, Friedman FK, Kung HF, Lin MC, Chung D, Pincus MR.
    J Protein Chem; 2002 Jul 24; 21(5):367-70. PubMed ID: 12206511
    [Abstract] [Full Text] [Related]

  • 29. Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.
    Waldmann H, Karaguni IM, Carpintero M, Gourzoulidou E, Herrmann C, Brockmann C, Oschkinat H, Müller O.
    Angew Chem Int Ed Engl; 2004 Jan 16; 43(4):454-8. PubMed ID: 14735533
    [No Abstract] [Full Text] [Related]

  • 30. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM, Oldham SM, Martin CB, Drugan JK, Zohn IE, Campbell S, Der CJ.
    Oncogene; 1999 Mar 25; 18(12):2107-16. PubMed ID: 10321735
    [Abstract] [Full Text] [Related]

  • 31. Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS.
    Shirouzu M, Morinaka K, Koyama S, Hu CD, Hori-Tamura N, Okada T, Kariya K, Kataoka T, Kikuchi A, Yokoyama S.
    J Biol Chem; 1998 Mar 27; 273(13):7737-42. PubMed ID: 9516482
    [Abstract] [Full Text] [Related]

  • 32. Design of inhibitors of Ras--Raf interaction using a computational combinatorial algorithm.
    Zeng J, Nheu T, Zorzet A, Catimel B, Nice E, Maruta H, Burgess AW, Treutlein HR.
    Protein Eng; 2001 Jan 27; 14(1):39-45. PubMed ID: 11287677
    [Abstract] [Full Text] [Related]

  • 33. Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling.
    Chen JM, Rijhwani K, Friedman FK, Hyde MJ, Pincus MR.
    J Protein Chem; 2000 Oct 27; 19(7):545-51. PubMed ID: 11233167
    [Abstract] [Full Text] [Related]

  • 34. Cell-free synthesis of the Ras-binding domain of c-Raf-1: binding studies to fluorescently labelled H-ras.
    Sydor JR, Seidel RP, Goody RS, Engelhard M.
    FEBS Lett; 1999 Jun 11; 452(3):375-8. PubMed ID: 10386625
    [Abstract] [Full Text] [Related]

  • 35. A two-hybrid approach to identify inhibitors of the RAS-RAF interaction.
    Khazak V, Eyrisch S, Kato J, Tamanoi F, Golemis EA.
    Enzymes; 2013 Jun 11; 33 Pt A():213-48. PubMed ID: 25033807
    [Abstract] [Full Text] [Related]

  • 36. Ras classical effectors: new tales from in silico complexes.
    Fuentes G, Valencia A.
    Trends Biochem Sci; 2009 Nov 11; 34(11):533-9. PubMed ID: 19801192
    [Abstract] [Full Text] [Related]

  • 37. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
    Chie L, Chen JM, Friedman FK, Chung DL, Amar S, Michl J, Yamaizumi Z, Brandt-Rauf PW, Pincus MR.
    J Protein Chem; 1999 Nov 11; 18(8):881-4. PubMed ID: 10839625
    [Abstract] [Full Text] [Related]

  • 38. Design, total chemical synthesis, and binding properties of a [Leu-91-N1-methyl-7-azaTrp]Ras-binding domain of c-Raf-1.
    Sydor JR, Herrmann C, Kent SB, Goody RS, Engelhard M.
    Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):7865-70. PubMed ID: 10393913
    [Abstract] [Full Text] [Related]

  • 39. Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation.
    Kimoto M, Shirouzu M, Mizutani S, Koide H, Kaziro Y, Hirao I, Yokoyama S.
    Eur J Biochem; 2002 Jan 06; 269(2):697-704. PubMed ID: 11856330
    [Abstract] [Full Text] [Related]

  • 40. Hypothesis: ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domains.
    van Blitterswijk WJ.
    Biochem J; 1998 Apr 15; 331 ( Pt 2)(Pt 2):679-80. PubMed ID: 9531568
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.